- Home
- KLTOW vs EVGOW Comparison
KLTOW vs EVGOW Comparison
Compare KLTOW & EVGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- EVGOW
- Stock Information
- Founded
- KLTOW N/A
- EVGOW 2010
- Country
- KLTOW United States
- EVGOW United States
- Employees
- KLTOW 3
- EVGOW 331
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- EVGOW Other Specialty Stores
- Sector
- KLTOW Health Care
- EVGOW Consumer Discretionary
- Exchange
- KLTOW Nasdaq
- EVGOW Nasdaq
- Market Cap
- KLTOW N/A
- EVGOW N/A
- IPO Year
- KLTOW 2022
- EVGOW N/A
- Fundamental
- Price
- KLTOW $0.25
- EVGOW $0.20
- Analyst Decision
- KLTOW
- EVGOW
- Analyst Count
- KLTOW 0
- EVGOW 0
- Target Price
- KLTOW N/A
- EVGOW N/A
- AVG Volume (30 Days)
- KLTOW N/A
- EVGOW 74.7K
- Earning Date
- KLTOW N/A
- EVGOW 03-07-2025
- Dividend Yield
- KLTOW N/A
- EVGOW N/A
- EPS Growth
- KLTOW N/A
- EVGOW N/A
- EPS
- KLTOW N/A
- EVGOW N/A
- Revenue
- KLTOW N/A
- EVGOW $239,306,000.00
- Revenue This Year
- KLTOW N/A
- EVGOW N/A
- Revenue Next Year
- KLTOW N/A
- EVGOW N/A
- P/E Ratio
- KLTOW N/A
- EVGOW N/A
- Revenue Growth
- KLTOW N/A
- EVGOW 73.08
- 52 Week Low
- KLTOW N/A
- EVGOW $0.12
- 52 Week High
- KLTOW N/A
- EVGOW $1.99
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- EVGOW 40.24
- Support Level
- KLTOW N/A
- EVGOW $0.19
- Resistance Level
- KLTOW N/A
- EVGOW $0.22
- Average True Range (ATR)
- KLTOW 0.00
- EVGOW 0.02
- MACD
- KLTOW 0.00
- EVGOW -0.00
- Stochastic Oscillator
- KLTOW 0.00
- EVGOW 37.38
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.